| 000 | 01764 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517213856.0 | ||
| 264 | 0 | _c20190205 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a1463-1326 | ||
| 024 | 7 |
_a10.1111/dom.13335 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOverbeek, Jetty A | |
| 245 | 0 | 0 |
_aClinical effectiveness of liraglutide vs basal insulin in a real-world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes. _h[electronic resource] |
| 260 |
_bDiabetes, obesity & metabolism _c09 2018 |
||
| 300 |
_a2093-2102 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulins _xadministration & dosage |
| 650 | 0 | 4 |
_aLiraglutide _xadministration & dosage |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 650 | 0 | 4 | _aPropensity Score |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aHeintjes, Edith M | |
| 700 | 1 | _aHuisman, Eline L | |
| 700 | 1 | _aTikkanen, Christian K | |
| 700 | 1 | _avan Diermen, Arnout W | |
| 700 | 1 | _aPenning-van Beest, Fernie J A | |
| 700 | 1 | _aHerings, Ron M C | |
| 773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 20 _gno. 9 _gp. 2093-2102 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/dom.13335 _zAvailable from publisher's website |
| 999 |
_c28356732 _d28356732 |
||